Technical / White Paper

New Guidelines Strengthen Good Distribution Practice (GDP)

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by RSSL, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

New Guidelines Strengthen Good Distribution Practice (GDP)

The recently introduced EU Guidelines on the Good Distribution Practice of Medicinal Products for Human Use, (first published on March 8th 2013 as 2013/C 68/01 and updated on November 5th 2013 as 2013/C 343/01) places significant new demands on the manufacturers and distributors of pharmaceutical products.

Partly driven by the need to prevent counterfeit and falsified medicines from entering the legitimate supply chain, 2013/C 343/01 sets out the necessary requirements to ensure compliance with Directive 2011/62/EU, the 'Falsified Medicines Directive'.

Moreover, the new guidelines also take account of the challenges (and opportunities) presented by new technologies and increasing globalisation, which have come about since the previous version was published in 1994.

Latest content from RSSL

show more

Extractables and leachables analysis of pharmaceutical products

Paid for and content provided by RSSL

Extractables and leachables analysis of pharmaceutical products

A crucial undertaking when releasing pharmaceutical products for the market, is to determine the purity of the final product, necessitating the need to determine its impurity profile. Traditionally, this was concerned only with those impurities arising...

The impact of particles on pharmaceuticals

Paid for and content provided by RSSL

The impact of particles on pharmaceuticals

Sometimes it's the smallest details that have the biggest impact on pharmaceutical performance. That's certainly true when it comes down to the properties of particles and their impact on pharmaceutical performance. Subtle changes in particle...

Related resources from RSSL

Show more

Supplier info centre